Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-066416

Anacor Pharmaceuticals, Inc. · ANAC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul L Berns
Officer — President and CEO · Director
Period of report
Aug 13, 2015
Accepted (ET)
Aug 17, 2015 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 13, 2015M20,000$5.11A274,760D
Common StockF3,F4Aug 13, 2015S1,655$136.4938D273,105D
Common StockF3,F5Aug 13, 2015S3,489$137.5249D269,616D
Common StockF3,F6Aug 13, 2015S3,281$138.397D266,335D
Common StockF3,F7Aug 13, 2015S11,575$139.445D254,760D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F8$5.11Aug 13, 2015M20,000D—Jun 6, 2023Common Stock20,0004,000D

Explanation of responses